Monthly Archives: October 2014

#WEWANTCHANGE: Five issues, five voices

IPI launches campaign highlighting challenges to press freedom worldwide VIENNA, Oct 30, 2014 – Criminal defamation laws, the imprisonment of journalists, violent attacks on journalists, endemic impunity for such crimes…

B. Braun Wins Patent Disputes Against Poly Medicure Ltd’s Australian Distributor Multigate Medical Devices Pty. Ltd. and Spanish Distributor Dextromedica S. L.

MELBOURNE, Australia and BARCELONA, Oct. 31, 2014 /PRNewswire/ — Multigate Medical Devices Pty Ltd (Multigate) was found to infringe two Australian patents of B. Braun Melsungen AG (B. Braun) by…

Specialised Therapeutics Australia Announces Breakthrough Cancer Drug Abraxane(R) to be PBS Listed for Metastatic Pancreatic Cancer

– ABRAXANE plus gemcitabine to be PBS listed for Australian patients with metastatic pancreatic cancer from 1 November – ABRAXANE plus gemcitabine significantly improves survival outcomes – A new standard…

VolitionRx Initiates Sponsorship of Two-time Cancer Survivor to Drive Awareness for the Importance of Early Cancer Detection

Corporate social responsibility initiative supports commitment to long-term quality of life for cancer survivors NAMUR, Belgium, October 31, 2014 /PRNewswire/ — VolitionRx Limited (OTCQB: VNRX), a life sciences company focused…

ThynkWare Speech Helps Those with ALS and Locked-In Syndrome Translate Thought to Speech on Their Smartphone Devices

MOUNTAIN VIEW, Calif., October 31, 2014 /PRNewswire/ — ThynkWare (www.thynkware.com) is seeking to help amyotrophic lateral sclerosis (ALS) patients initiate text and email messages using their thoughts. ThynkWare Speech is…

U.S. FDA Cardiovascular and Renal Drugs Advisory Committee Makes Recommendation on Daiichi Sankyo’s Once-Daily SAVAYSA(TM) (edoxaban) for the Reduction in Risk of Stroke and Systemic Embolic Events in Patients with Non-Valvular Atrial Fibrillation

– Committee votes 9 to 1 to recommend approval of once-daily SAVAYSA for the reduction in risk of stroke and systemic embolic events (SEE) in patients with non-valvular atrial fibrillation…

Transforming healthcare — 65 global experts on ‘What Works’

— Healthcare organizations must think long-term to solve today’s problems LONDON, Oct. 31, 2014 /PRNewswire/ — Challenges facing the healthcare sector are well known, yet governments and private sector organizations struggle with…

Hundreds Of Children In Afghanistan Receive Free Hearing Aids

– The Bayat Foundation and Starkey Hearing Foundation partner to bring the gift of hearing to conflict regions in Afghanistan. KABUL, Afghanistan, Oct. 31, 2014 /PRNewswire/ — Last week the…

Irvine Pharmaceutical Services Announces the Opening of an Analytical Facility in Hangzhou, China

IRVINE, Calif., Oct. 30, 2014 /PRNewswire/ — Irvine Pharmaceutical Services, Inc., a leading provider in cGMP contract development and parenteral manufacturing services, announces plans to open a new facility in Hangzhou, China.…